Genmab A/S (GNMSF) Assets (2019 - 2026)
Genmab A's (GNMSF) quarterly Assets came in at $12.4 billion in Q1 2026, up 87.91% YoY from $6.6 billion in Q1 2025, and down 3.86% on a QoQ basis from $12.9 billion in Q4 2025.
Genmab A/S (GNMSF) Assets (2019 - 2026) Analysis & Trends
Genmab A (GNMSF) has 6 years of Assets data on file, last reported at $12.4 billion in Q1 2026.
- Quarterly Assets rose 87.91% year-over-year to $12.4 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $12.4 billion (up 87.91% YoY) and the FY2025 annual result came in at $12.9 billion, up 100.7% from the prior year.
- Assets eased to $12.4 billion in Q1 2026, from $12.9 billion in the prior quarter.
- In the past five years, Assets ranged from a high of $12.9 billion in Q4 2025 to a low of $5.2 billion in Q4 2023.
- A 4-year average of $8.1 billion and a median of $6.6 billion in 2025 frame the typical range for Assets.
- Annual changes were most pronounced in 2024 — Assets increased 22.59% — and 2025, when it surged 100.7%.
- Tracing GNMSF's Assets over 4 years: stood at $5.2 billion in 2023, then increased by 22.59% to $6.4 billion in 2024, then jumped by 100.7% to $12.9 billion in 2025, then slipped by 3.86% to $12.4 billion in 2026.
- The last three Assets figures came in at $12.4 billion (Q1 2026), $12.9 billion (Q4 2025), and $7.0 billion (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 12.52 Bn |
| Mar 31, 2026 | 12.38 Bn |
| Dec 31, 2025 | 12.87 Bn |
| Sep 30, 2025 | 7.02 Bn |
| Jun 30, 2025 | 6.46 Bn |
| Mar 31, 2025 | 6.59 Bn |
| Dec 31, 2024 | 6.41 Bn |
| Dec 31, 2023 | 5.23 Bn |
| Sep 30, 2020 | 21,522,000.00 Bn |
| Dec 31, 2019 | 15,035.00 |
| Sep 30, 2019 | 13,330,000.00 Bn |